Aug 22, 2013
172:171
For every 171 shares held, investors received 172. The price per share adjusted from $171.00 to $170.01.
The split itself did not change the total investment value.
Medigen Biotechnology Corporation (TPEX:3176) operates in the Pharmaceuticals: major industry.
Medigen Biotechnology Corporation company overviewMedigen Biotechnology Corporation's most recent stock split was on August 22, 2013. It was a 172-for-171 forward split, so shareholders received 172 shares for every 171 they held.
Medigen Biotechnology Corporation (TPEX:3176) has split its stock 5 times: a 379-for-368 split on July 16, 2007, a 1021-for-1000 split on June 26, 2008, a 484-for-471 split on September 3, 2010, a 303-for-292 split on April 12, 2012, and a 172-for-171 split on August 22, 2013.
Medigen Biotechnology Corporation has split its stock 5 times. This history records 5 forward splits between July 16, 2007 and August 22, 2013.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Medigen Biotechnology Corporation's 172-for-171 split on August 22, 2013, every 171 shares became 172 shares.
Medigen Biotechnology Corporation has not announced a new split in our records. Its most recent split was on August 22, 2013, 13 years ago. Companies announce splits in advance, and any new TPEX:3176 split will appear on this page.
Already premium?